Pet imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in progressive multifocal leukoencephalopathy

7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

The use of positron emission tomography (PET) imaging in progressive multifocal leukoencephalopathy (PML) has rarely been reported. We herein report a set of PET images in a 63-year-old patient with PML. In PML lesions, the uptake of 18F-fluorodeoxyglucose, 11C-methionine, 11C-flumazenil, and [methyl-11C]4’-thiothymidine was decreased, increased, decreased, and unchanged, respectively. These results suggest that glucose metabolism decreased, protein synthesis increased, neuronal integrity decreased, and the DNA synthesis and cellular proliferation of host cells were not activated in PML lesions. These results may reflect very little infiltration by inflammatory cells and active infection with JC virus in this case.

Cite

CITATION STYLE

APA

Ishibashi, K., Miura, Y., Matsumura, K., Kanemasa, Y., Nakamichi, K., Saijo, M., … Ishii, K. (2017). Pet imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in progressive multifocal leukoencephalopathy. Internal Medicine, 56(10), 1219–1223. https://doi.org/10.2169/internalmedicine.56.8080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free